News on Vascular Solutions Incorporated from BioPortfolio.com http://www.BioPortfolio.com Consolidated Vascular Solutions Incorporated news from BioPortfolio.com Wed, 10 Feb 2010 13:09:58 GMT en Tenaxis Medical, Inc. Announces Completion Of The Enrollment Phase Of Their Pivotal Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024911&HITNO=0&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024911&THISHREF=http://c.moreover.com/click/here.pl%3fz2529259074%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024911&HITNO=0&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024911&THISHREF=http://c.moreover.com/click/here.pl%3fz2529259074%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: P.A.D. Task Force Committee: BioMedix Vascular Solutions invited to participatehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020098&HITNO=1&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020098&THISHREF=http://c.moreover.com/click/here.pl%3fz2526598029%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020098&HITNO=1&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020098&THISHREF=http://c.moreover.com/click/here.pl%3fz2526598029%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Vascular Solutions Launches Gator ClipSeal Plughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023116&HITNO=2&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023116&THISHREF=http://c.moreover.com/click/here.pl%3fz2528035676%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023116&HITNO=2&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023116&THISHREF=http://c.moreover.com/click/here.pl%3fz2528035676%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTCTMD.com: ISCR hosted 3rd annual conference in Bengaluruhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019261&HITNO=3&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019261&THISHREF=http://c.moreover.com/click/here.pl%3fz2526197460%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019261&HITNO=3&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019261&THISHREF=http://c.moreover.com/click/here.pl%3fz2526197460%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comExpress Pharma: Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012576&HITNO=4&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012576&THISHREF=http://c.moreover.com/click/here.pl%3fz2523467433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012576&HITNO=4&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012576&THISHREF=http://c.moreover.com/click/here.pl%3fz2523467433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Finance: Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012527&HITNO=5&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012527&THISHREF=http://c.moreover.com/click/here.pl%3fz2523455059%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012527&HITNO=5&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012527&THISHREF=http://c.moreover.com/click/here.pl%3fz2523455059%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Vascular Solutions board approves buyback planhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002269&HITNO=6&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002269&THISHREF=http://c.moreover.com/click/here.pl%3fz2518831765%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002269&HITNO=6&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002269&THISHREF=http://c.moreover.com/click/here.pl%3fz2518831765%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioscience Technology Online: Vascular Solutions 4Q profit falls on taxeshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002270&HITNO=7&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002270&THISHREF=http://c.moreover.com/click/here.pl%3fz2518831962%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002270&HITNO=7&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002270&THISHREF=http://c.moreover.com/click/here.pl%3fz2518831962%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioscience Technology Online: CareFusion Announces 5-Year, Sole Source Pyxis(R) Perioperative Solutions Agreement With CHRISTUS Healthhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002843&HITNO=8&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002843&THISHREF=http://c.moreover.com/click/here.pl%3fz2519194214%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002843&HITNO=8&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002843&THISHREF=http://c.moreover.com/click/here.pl%3fz2519194214%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEP Lab Digest: Vascular Solutions Announces Record Fourth Quarter Results; Net Revenue Increases 11% to Record $18http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001405&HITNO=9&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001405&THISHREF=http://c.moreover.com/click/here.pl%3fz2518412514%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001405&HITNO=9&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001405&THISHREF=http://c.moreover.com/click/here.pl%3fz2518412514%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInterest!ALERT: Wipro and Trend Micro Unite to Deliver Next-Generation Virtualization Security Solutions for Dynamic Datacentershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990373&HITNO=10&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990373&THISHREF=http://c.moreover.com/click/here.pl%3fz2513292283%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990373&HITNO=10&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990373&THISHREF=http://c.moreover.com/click/here.pl%3fz2513292283%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: YM BioSciences completes merger with Cytopiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991467&HITNO=11&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991467&THISHREF=http://c.moreover.com/click/here.pl%3fz2513718832%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991467&HITNO=11&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991467&THISHREF=http://c.moreover.com/click/here.pl%3fz2513718832%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTickerTech.com: YM BioSciences completes merger with Cytopiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991464&HITNO=12&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991464&THISHREF=http://c.moreover.com/click/here.pl%3fz2513718082%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991464&HITNO=12&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991464&THISHREF=http://c.moreover.com/click/here.pl%3fz2513718082%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTickerTech.com: Tenaxis Medical, Inc. Announces Completion of the Enrollment Phase of Their Pivotal Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960215&HITNO=13&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960215&THISHREF=http://c.moreover.com/click/here.pl%3fz2496105886%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960215&HITNO=13&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960215&THISHREF=http://c.moreover.com/click/here.pl%3fz2496105886%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTickerTech.com: AMAG Pharmaceuticals Announces Pricing of Public Offering of 3,600,000 Shares of Common Stockhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956531&HITNO=14&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956531&THISHREF=http://c.moreover.com/click/here.pl%3fz2494592170%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956531&HITNO=14&MSIZE=72&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vascular%20Solutions%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956531&THISHREF=http://c.moreover.com/click/here.pl%3fz2494592170%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: